Meeting Archive:
PH Treatments: What's on the Horizon

This event has already taken place. The recording will be available soon on PHA Classroom.
PHA is always scheduling more webinars on relevant and important topics. We have more than 170 recordings posted from past live events and our international conference. For more information on upcoming webinars or to watch recordings, visit PHA Classroom.

Meeting Description:
With the recent FDA approval of three new treatments in just a few months, the past year has brought exciting advances in PH research! Join Dr. Michael McGoon of the Mayo Clinic for a presentation on the current treatments available for PH, as well as new treatments in the pipeline.
Date: Tue, Apr 29, 2014
Time: 01:00 PM EDT
Duration: 1 hour
Host(s): PHA Classroom
 Presenter Information
Michael McGoon, MD
Speaker Photo

Michael McGoon, MD, is Professor of Medicine and Consultant in Cardiovascular Diseases at Mayo Clinic, Rochester, Minnesota. Dr. McGoon attended medical school and completed internship at Johns Hopkins before transferring to Mayo for residency and cardiology training. Dr. McGoon served as Director of the PH Center at Mayo since he initiated it in 1996 until 2007. He is board certified in Internal Medicine and Cardiology. For over 25 years, he has led multiple clinical trials of PH medications, starting with intravenous prostacyclin.  He recently served as chair of the Steering Committee of the REVEAL registry. Dr. McGoon has been a member of PHA’s Scientific Leadership Council since 1994, serving as Chair from 2002 to 2004 and as a Distinguished Advisor since 2004. He was Chair of the Board of Trustees of PHA (2006-2008), and currently chairs the Pulmonary Hypertension Care Centers Oversight Committee.